Half of apartment dwellers in Los Angeles report having been exposed to unwanted secondhand smoke in their homes in the last year, and 9 in 10 of them say they favor policies banning smoking from their buildings, a new study by researchers at the Fielding School of Public Health's UCLA Center for Health Policy Research reveals.
UCLA Asian American Studies Center and the UCLA Fielding School of Public Health COVID-19 Multilingual Resource Hub to support safety for diverse communities; partnership develops resources for COVID-19 response
Emre Umucu, Ph.D., assistant professor of rehabilitation counseling at The University of Texas at El Paso, and Beatrice Lee, an incoming rehabilitation counseling faculty member, examined the perceived stress levels and coping mechanisms related to COVID-19, and how coping affects well-being in people with self-reported chronic conditions and disabilities.
access_time Embargo lifts in 2 days
Embargo will expire:
4-Jun-2020 5:00 PM EDT
Released to reporters: 29-May-2020 6:10 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 4-Jun-2020 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology and oncology for Atlantic Health System. Early results appear promising in this phase 1/2 clinical trial of ADXS-503 being developed by Advaxis, Inc., a new type of cancer therapy which targets “hotspot” mutations that commonly occur in specific cancer types, both by itself and in combination with immunotherapy Keytruda® (pembrolizumab), which is commonly used to treat this type of lung cancer. Dr. Haigentz and colleagues published early results of this study in conjunction with ASCO 2020, the world’s premier scientific meeting for clinical research in oncology.
The more people know about when and why behavioural interventions are being used and their effectiveness, the more likely they are to accept their use to change their behaviour, according to recent research from Queen Mary University of London and the University of Oxford.
An investigation published open-access in the American Journal of Roentgenology (AJR) revealed a high frequency of negative chest CT findings among pediatric patients with laboratory-confirmed coronavirus disease (COVID-19), while also suggesting that bilateral, lower lobe-predominant ground-glass opacities (GGOs) are common in the subset of patients with positive CT findings.
If physical distancing measures in Ontario are relaxed too much or too quickly, the province could see hospitals overwhelmed with COVID-19 patients as well as exponential growth in deaths, concludes new research involving a University of Guelph infectious disease modeller.